These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11791116)

  • 1. New strategies for the treatment of breast cancer.
    Bentrem DJ; O'Regan RM; Jordan VC
    Breast Cancer; 2001; 8(4):265-74. PubMed ID: 11791116
    [No Abstract]   [Full Text] [Related]  

  • 2. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: the example of clinical studies].
    Giannessi PG
    Suppl Tumori; 2004; 3(4):S73-4. PubMed ID: 15206218
    [No Abstract]   [Full Text] [Related]  

  • 3. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: what kind of evidence?].
    Angiolini C
    Suppl Tumori; 2004; 3(4):S75-6. PubMed ID: 15206219
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of breast cancer.
    Thomsen A; Kolesar JM
    Am J Health Syst Pharm; 2008 Dec; 65(23):2221-8. PubMed ID: 19020189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate ATAC on tamoxifen.
    Coates A; Mouridsen H; Thürlimann B;
    Lancet Oncol; 2008 Apr; 9(4):315-6. PubMed ID: 18374287
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
    Buzdar AU
    Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research.
    Hayward RL; Dixon JM
    Surg Oncol; 2003 Dec; 12(4):289-304. PubMed ID: 14998569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Du XL
    J Natl Cancer Inst; 2003 May; 95(9):683; author reply 684-5. PubMed ID: 12734321
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiestrogenic agents for treatment of advanced breast cancers].
    Kimura M
    Nihon Rinsho; 2000 Apr; 58 Suppl():311-6. PubMed ID: 11026011
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
    J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
    Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
    Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current controversies in breast cancer management.
    Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
    Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Chagunava OL
    Vopr Onkol; 1998; 44(4):408-13. PubMed ID: 9807203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Playing the old piano: another tune for endocrine therapy?
    Hayes DF
    J Natl Cancer Inst; 2003 Nov; 95(21):1565-7. PubMed ID: 14600082
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
    Lippman SM; Brown PH
    J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant therapy for all patients with breast cancer?
    Lippman ME; Hayes DF
    J Natl Cancer Inst; 2001 Jan; 93(2):80-2. PubMed ID: 11208870
    [No Abstract]   [Full Text] [Related]  

  • 19. To switch or not to switch: should the study of tamoxifen and raloxifene (STAR) trial alter our decision?
    Wang PH; Chao HT
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):372-4. PubMed ID: 18936014
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
    J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.